Computer Simulation of Prostate Biopsies

Slides:

Advertisements

Similar presentations

RISK OF NON SIGNIFICANT PROSTATE CANCER IN PROSTATE CANCER PATIENTS DIAGNOSED BY AN EXTENDED PROSTATE NEEDLE BIOPSY PROCEDURE AND TREATED BY RADICAL PROSTATECTOMY.

Advertisements

Volume 42, Issue 1, Pages 7-11 (July 2002)

Volume 61, Issue 5, Pages (May 2012)

Volume 50, Issue 3, Pages (September 2006)

The PSA Era is not Over for Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

Volume 4, Issue 5, Pages (September 2017)

Volume 70, Issue 5, Pages (November 2016)

Prostate Cancer 2008: Challenges in Diagnosis and Management

Volume 60, Issue 1, Pages (July 2011)

Nerve-sparing Radical Cystectomy: A New Technique

Volume 46, Issue 3, Pages (September 2004)

Volume 67, Issue 3, Pages (March 2015)

Seminal Vesicle Invasion by Adenocarcinoma of the Prostate

Volume 73, Issue 5, Pages (May 2018)

Dynamic Contrast-Enhanced MRI for Preoperative Identification of Localised Prostate Cancer Arnauld Villers, Philippe Puech, Xavier Leroy, Jacques Biserte,

Prostate Cancer Epidemic in Sight?

Volume 72, Issue 3, Pages (September 2017)

Volume 58, Issue 1, Pages (July 2010)

Volume 63, Issue 4, Pages e53-e56 (April 2013)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Back to the Future: Introduction and Conclusions

Volume 54, Issue 4, Pages (October 2008)

Pitfalls of Pathologic Staging in Prostate Cancer

What is New in Hormone Therapy for Prostate Cancer in 2007?

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 54, Issue 5, Pages (November 2008)

Volume 68, Issue 3, Pages (September 2015)

Treatment of Symptomatic Benign Prostatic Hyperplasia: Current and Future Clinical Practice in Europe – What is Really Happening? Bob Djavan European.

Counselling the Prostate Cancer Patient

Laurent Boccon-Gibod European Urology Supplements

Luis Martínez-Piñeiro European Urology Supplements

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 72, Issue 5, Pages (November 2017)

Volume 61, Issue 5, Pages (May 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

11C-Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate Cancer I.J de Jong, J Pruim, P.H Elsinga, W Vaalburg,

Open versus Laparoscopic Radical Prostatectomy

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Tillmann Loch, Pat Fox Fulgham European Urology

Volume 41, Issue 2, Pages (February 2002)

Richard C. Harkaway European Urology Supplements

Uropathology European Urology

Volume 65, Issue 1, Pages (January 2014)

Volume 50, Issue 5, Pages (November 2006)

Optimising Hormone Therapy in Advanced Disease

Biopsy of the Vesico-Urethral Anastomosis after Radical Prostatectomy: When and How Vincenzo Scattoni, Marco Roscigno, Marco Raber, Paolo Consonni, Luigi.

The Importance of Testosterone Control in Prostate Cancer

Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice Claus Roehrborn European Urology.

Neal Shore European Urology Supplements

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

PSA Levels and the Probability of Prostate Cancer on Biopsy

How and When to Take Prostate Biopsies

Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg

Volume 49, Issue 6, Pages (June 2006)

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Prostate Cancer 2008: Challenges in Diagnosis and Management

Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.

Volume 69, Issue 1, Pages (January 2016)

The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review Fritz Schröder,

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Epidemiology and Demographics of Prostatitis

Does PSA Testing Influence the Natural History of Prostate Cancer?

Volume 51, Issue 5, Pages (May 2007)

Michael Marberger European Urology Supplements

Introduction European Urology Supplements

Presentation transcript:

Computer Simulation of Prostate Biopsies Tillmann Loch, Michael E Chen European Urology Supplements Volume 1, Issue 6, Pages 47-51 (September 2002) DOI: 10.1016/S1569-9056(02)00058-1

Fig. 1 Schematic drawing of tumor location from 73 radical prostatectomies (cancer locations: brown; peripheral zone: yellow; transition zone: blue; stroma: green; accepted by McNeal and co-workers [1]). European Urology Supplements 2002 1, 47-51DOI: (10.1016/S1569-9056(02)00058-1)

Fig. 2 Systematic sextant biopsies. Longitudinal cross-section of the left lobe (a) and right lobe of the prostate (b) with small tumor foci. PZ: peripheral zone; TZ: transition zone; SB: seminal vesicles. European Urology Supplements 2002 1, 47-51DOI: (10.1016/S1569-9056(02)00058-1)

Fig. 3 Classical mid-lobar systematic sextant biopsies and more lateral directed modified systematic sextant biopsies for better tumor volume estimation. CA: Cancer; TZ-BHP: Tranzition Zone-Benign Prostatic Hyperplasia; PZ: Peripheral Zone. European Urology Supplements 2002 1, 47-51DOI: (10.1016/S1569-9056(02)00058-1)

Fig. 4 Three-dimensional model of an optimized virtual prostate biopsy. Model can be viewed from different perspectives (a and b). European Urology Supplements 2002 1, 47-51DOI: (10.1016/S1569-9056(02)00058-1)